IP Library › Granted Patent US 12,460,081
Granted Patent B2
US 12,460,081 · App. 18/058,762 · Granted Nov 4, 2025

Curable condensation compounds based on alkoxy-functional polysiloxanes

Inventors: Berend-Jan de Gans (Muelheim an der Ruhr, DE); Wilfried Knott (Essen, DE); Horst Dudzik (Essen, DE); Markus Hallack (Schermbeck, DE); Florian Düllmann (Hagen, DE); Philippe Favresse (Ratingen, DE)
Assignee: Evonik Operations GmbH
C08L83/06C08G77/08C09D183/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,460,081
App. No.
18/058,762
Granted
Nov 4, 2025
Kind
B2
Abstract

Curable condensation compounds are obtainable by a reaction of non-end-equilibrated acetoxy group-bearing siloxanes with at least one alkoxy-functional polysiloxane, in the presence of a catalyst.

Claims (45)

1 . A curable condensation compound, obtained by a reaction of:

acetoxy group-bearing siloxanes of formula (I):

wherein R=an alkyl radical having 1 to 4 carbon atoms and/or phenyl radical, and 1≤x≤500,

wherein the acetoxy group-bearing siloxanes of formula (I) have not been end-equilibrated,

with

at least one alkoxy-functional polysiloxane of the formula (II)

R 1 c Si(OR 2 ) d O (4-c-d)/2   Formula (II)

wherein c is not less than 0 to not more than 2, d is not less than 0 to not more than 4, and a sum total of c+d is less than 4,

R 1 is the same or different and is independently a linear or branched, saturated or else mono- or polyunsaturated or aromatic hydrocarbon radical, and

R 2 is an alkyl group consisting of 1 to 8 carbon atoms, and

in the presence of a catalyst.

2 . The condensation compound according to claim 1 , wherein the non-end-equilibrated acetoxy group-bearing siloxanes of formula (I) are obtainable by a reaction of linear α,ω-hydroxy group-bearing polysiloxanes with acetic anhydride.

3 . The condensation compound according to claim 1 , wherein the acetoxy group-bearing siloxanes of formula (I) have exclusively D units.

4 . The condensation compound according to claim 1 , wherein the acetoxy group-bearing siloxanes of formula (I) are α,ω-acetoxy group-bearing linear polydimethylsiloxanes.

5 . The condensation compound according to claim 1 , wherein in the at least one alkoxy-functional polysiloxane, R 1 =a methyl or phenyl radical.

6 . The condensation compound according to claim 1 , wherein a weight-average molecular weight of the at least one alkoxy-functional polysiloxane is 200 to 20,000 g/mol.

7 . The condensation compound according to claim 1 , wherein an alkoxy functionality of the at least one alkoxy-functional polysiloxane is from 50% to 3% by weight, based on a total mass of the at least one alkoxy-functional polysiloxane.

8 . The condensation compound according to claim 1 , wherein the catalyst is selected from the group consisting of tin diacetate, tin dioctoate, dibutyltin diacetylacetonate, dibutyltin dilaurate, tin tetraacetate, dibutyltin diacetate, dibutyltin dioctoate, dibutyltin dioleate, dimethoxydibutyttin, dimethyltin, dibutyltinbenzyl maleate, bis(triethoxysiloxy)dibutyltin, diphenyltin diacetate, dioctyltin dilaurate, dioctyltin dineodecanoate, tetraethoxytitanium, tetra-n-propoxytitanium, tetraisopropoxytitanium, tetra-n-butoxytitanium, tetraisobutoxytitanium, tetrakis(2-ethylhexoxy)titanium, diisopropoxybis(ethylacetoacetato)titanium, dipropoxybis(acetylacetonato)titanium, diisopropoxybis(acetylacetonato)titanium, dibutoxybis(acetylacetonato)titanium, trisopropoxyallyltitanium acetate, isopropoxyoctylene glycol-titanium oxide or bis(acetylacetonato)titanium oxide, lead diacetate, lead di-2-ethylhexanoate, lead dineodecanoate, lead tetraacetate, lead tetrapropionate, zinc acetylacetonate, zinc 2-ethylcaproate, zinc diacetate, bis(2-ethylhexanoyl)zinc, zinc dineodecanoate, zinc diundecenoate, zinc dimethacrylate, tetrakis(2-ethylhexanoyl)zirconium dichloride, tetrakis(methacryloyl)zirconium dichloride, cobalt diacetate, bismuth carboxylate, and bismuth triflate.

9 . The condensation compound according to claim 1 , wherein the reaction includes at least one crosslinker of formula (IV)

R 3 e Si(OR 4 ) f   Formula (IV)

wherein e is not less than 0 to not more than 2, f is not less than 2 to not more than 4, and a sum total of e+f is 4,

R 3 =a saturated or unsaturated alkyl group consisting of 1 to 8 carbon atoms or an aromatic moiety having 6 to 20 carbon atoms, and

R 4 =an alkyl or acyl group consisting of 1 to 8 carbon atoms.

10 . The condensation compound according to claim 9 , wherein the at least one crosslinker is selected from the group consisting of methyltriacetoxysilane, ethyltriacetoxysilane, dimethyldiacetoxysilane, methyltrimethoxysilane, methyltriethoxysilane, vinyltimethoxysilane, vinyltriethoxysilane, tetramethoxysilane, tetraethoxysilane, phenyltrethoxysilane, phenyltrimethoxysilane, propyltimethoxysilane, propyltriethoxysilane, dimethyldimethoxysilane, dimethyldiethoxysilane, dimethoxyphenylmethylsilane, and diethoxyphenylmethylsilane.

11 . A process for preparing the condensation compound according to claim 1 , the process comprising:

reacting the non-end-equilibrated acetoxy group-bearing siloxanes of formula (I) with the at least one alkoxy-functional polysiloxane of the formula (II) in the presence of the catalyst.

12 . The process according to claim 11 , wherein a weight ratio of the acetoxy group-bearing siloxanes of formula (I) to the at least one alkoxy-functional polysiloxane of formula (II) is 1:99 to 99:1, based on an overall silicone matrix.

13 . The process according to claim 11 , wherein the catalyst is formed in situ or prior to the reaction.

14 . The process according to claim 11 , wherein the acetoxy group-bearing siloxanes of formula (I) have D units.

15 . The process according to claim 11 , wherein the acetoxy group-bearing siloxanes of formula (I) are non-end-equilibrated α,ω-acetoxy group-bearing linear polydimethylsiloxanes.

16 . The process according to claim 11 , wherein in the at least one alkoxy-functional polysiloxane, R 1 =a methyl or phenyl radical.

17 . The process according to claim 11 , wherein an alkoxy functionality of the at least one alkoxy-functional polysiloxane is from 50% to 3% by weight, based on a total mass of the at least one alkoxy-functional polysiloxane.

18 . The process according to claim 11 , wherein the catalyst is selected from the group consisting of tin diacetate, tin dioctoate, dibutytin diacetylacetonate, dibutyltin dilaurate, tin tetraacetate, dibutyltin diacetate, dibutyltin dioctoate, dibutyltin dioleate, dimethoxydibutyltin, dimethyltin, dibutyltinbenzyl maleate, bis(triethoxysiloxy)dibutyltin, diphenyltin diacetate, dioctyltin dilaurate, dioctyltin dineodecanoate, tetraethoxytitanium, tetra-n-propoxytitanium, tetraisopropoxytitanium, tetra-n-butoxytitanium, tetraisobutoxytitanium, tetrakis(2-ethylhexoxy)titanium, diisopropoxybis(ethylacetoacetato)titanium, dipropoxybis(acetylacetonato)titanium, diisopropoxybis(acetylacetonato)titanium, dibutoxybis(acetylacetonato)titanium, triisopropoxyallyltitanium acetate, isopropoxyoctylene glycol-titanium oxide or bis(acetylacetonato)titanium oxide, lead diacetate, lead di-2-ethylhexanoate, lead dineodecanoate, lead tetraacetate, lead tetrapropionate, zinc acetylacetonate, zinc 2-ethylcaproate, zinc diacetate, bis(2-ethylhexanoyl)zinc, zinc dineodecanoate, zinc diundecenoate, zinc dimethacrylate, tetrakis(2-ethylhexanoyl)zirconium dichloride, tetrakis(methacryloyl)zirconium dichloride, cobalt diacetate, bismuth carboxylate, and bismuth triflate.

19 . The process according claim 11 , wherein the condensation reaction is complete with respect to acetoxysiloxane/silane used.

20 . The process according to claim 11 , wherein the reaction includes at least one crosslinker of formula (IV)

R 3 e Si(OR 4 ) f   Formula (IV)

wherein e is not less than 0 to not more than 2, f is not less than 2 to not more than 4, and a sum total of e+f is 4,

R 3 =a saturated or unsaturated alkyl group consisting of 1 to 8 carbon atoms or an aromatic moiety having 6 to 20 carbon atoms, and

R 4 =an alkyl or acyl group consisting of 1 to 8 carbon atoms.

21 . The process according to claim 20 , wherein the at least one crosslinker is selected from the group consisting of methyltriacetoxysilane, ethyltriacetoxysilane, dimethyldiacetoxysilane, methyltrimethoxysilane, methyltriethoxysilane, vinyltrimethoxysilane, vinyltriethoxysilane, tetramethoxysilane, tetraethoxysilane, phenyltriethoxysilane, phenyltrimethoxysilane, propyltrimethoxysilane, propyltriethoxysilane, dimethyldimethoxysilane, dimethyldiethoxysilane, and dimethoxyphenylmethylsilane.

22 . The process according to claim 11 , wherein an acetic ester formed from the R 2 radical and the acetoxy group is removed during the reaction.

23 . The process according to claim 22 , wherein the acetic ester formed is removed from the reaction by distillation and/or optionally with application of an auxiliary vacuum.

24 . A method, comprising:

producing a coating with the curable condensation compound according to claim 1 .

25 . A coated product, having a coating comprising the condensation compound according to claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2023
From: DE GANS, BEREND-JAN; KNOTT, WILFRIED; DUDZIK, HORST; HALLACK, MARKUS; DÜLLMANN, FLORIAN; FAVRESSE, PHILIPPE
To: EVONIK OPERATIONS GMBH
Reel/Frame 062469/0891 →
Priority Claims (1)
EP 21210450 · Nov 25, 2021 · regional
Continuity (1)
Related Publication 20230159756A1 · May 25, 2023
References Cited (143)
US 3032529A · Clark · 1962 [cited by applicant]
US 4585705A · Broderick et al. · 1986 [cited by applicant]
US 5357024A · Leclaire · 1994 [cited by applicant]
US 5371161A · Knott · 1994 [cited by applicant]
US 7196153B2 · Burkhart et al. · 2007 [cited by applicant]
US 7598334B2 · Ferenz et al. · 2009 [cited by applicant]
US 7612158B2 · Burkhart et al. · 2009 [cited by applicant]
US 7612159B2 · Burkhart et al. · 2009 [cited by applicant]
US 7645848B2 · Knott et al. · 2010 [cited by applicant]
US 7825205B2 · Knott et al. · 2010 [cited by applicant]
US 7825206B2 · Neumann et al. · 2010 [cited by applicant]
US 7825209B2 · Knott et al. · 2010 [cited by applicant]
US 7838603B2 · Schwab et al. · 2010 [cited by applicant]
US 8138294B2 · Henning et al. · 2012 [cited by applicant]
US 8283422B2 · Schubert et al. · 2012 [cited by applicant]
US 8309664B2 · Knott et al. · 2012 [cited by applicant]
US 8309673B2 · Schubert et al. · 2012 [cited by applicant]
US 8420748B2 · Henning et al. · 2013 [cited by applicant]
US 8450514B2 · Schubert et al. · 2013 [cited by applicant]
US 8598295B2 · Henning et al. · 2013 [cited by applicant]
US 8623984B2 · Henning et al. · 2014 [cited by applicant]
US 8722834B2 · Knott et al. · 2014 [cited by applicant]
US 8779079B2 · Henning et al. · 2014 [cited by applicant]
US 8946369B2 · Henning et al. · 2015 [cited by applicant]
US 9068044B2 · Schubert et al. · 2015 [cited by applicant]
US 9975909B2 · Schubert et al. · 2018 [cited by applicant]
US 10399998B2 · Knott et al. · 2019 [cited by applicant]
US 10414871B2 · Knott et al. · 2019 [cited by applicant]
US 10752735B2 · Knott et al. · 2020 [cited by applicant]
US 10766913B2 · Knott et al. · 2020 [cited by applicant]
US 10954344B2 · Knott et al. · 2021 [cited by applicant]
US 11021575B2 · Knott et al. · 2021 [cited by applicant]
US 11066429B2 · Knott et al. · 2021 [cited by applicant]
US 11220578B2 · Knott et al. · 2022 [cited by applicant]
US 11236204B2 · Favresse et al. · 2022 [cited by applicant]
US 11261298B2 · Favresse et al. · 2022 [cited by applicant]
US 11279804B2 · Knott et al. · 2022 [cited by applicant]
US 11286351B2 · Knott et al. · 2022 [cited by applicant]
US 11286366B2 · Knott et al. · 2022 [cited by applicant]
US 11345783B2 · Knott et al. · 2022 [cited by applicant]
US 11359056B2 · Knott et al. · 2022 [cited by applicant]
US 11377523B2 · Favresse et al. · 2022 [cited by applicant]
US 11420985B2 · Knott et al. · 2022 [cited by applicant]
US 11472822B2 · Knott et al. · 2022 [cited by applicant]
US 11498996B2 · Knott et al. · 2022 [cited by applicant]
US 20020161158A1 · Burkhart et al. · 2002 [cited by applicant]
US 20040132951A1 · Burkhart et al. · 2004 [cited by applicant]
US 20040147703A1 · Burkhart et al. · 2004 [cited by applicant]
US 20060155089A1 · Ferenz et al. · 2006 [cited by applicant]
US 20060241270A1 · Burkhart et al. · 2006 [cited by applicant]
US 20070049717A1 · Knott et al. · 2007 [cited by applicant]
US 20080153934A1 · Neumann et al. · 2008 [cited by applicant]
US 20080153992A1 · Knott et al. · 2008 [cited by applicant]
US 20080153995A1 · Knott et al. · 2008 [cited by applicant]
US 20080221276A1 · Schwab et al. · 2008 [cited by applicant]
US 20090226609A1 · Boisvert et al. · 2009 [cited by applicant]
US 20100041910A1 · Schubert et al. · 2010 [cited by applicant]
US 20100056649A1 · Henning et al. · 2010 [cited by applicant]
US 20100081781A1 · Schubert et al. · 2010 [cited by applicant]
US 20100105843A1 · Knott et al. · 2010 [cited by applicant]
US 20100168367A1 · Schubert et al. · 2010 [cited by applicant]
US 20100249339A1 · Henning et al. · 2010 [cited by applicant]
US 20100298455A1 · Henning et al. · 2010 [cited by applicant]
US 20110021693A1 · Henning et al. · 2011 [cited by applicant]
US 20110172373A1 · Knott et al. · 2011 [cited by applicant]
US 20110245412A1 · Schubert et al. · 2011 [cited by applicant]
US 20110301254A1 · Knott et al. · 2011 [cited by applicant]
US 20120046486A1 · Henning et al. · 2012 [cited by applicant]
US 20120296125A1 · Schubert et al. · 2012 [cited by applicant]
US 20130041115A1 · Knott et al. · 2013 [cited by applicant]
US 20130217907A1 · Henning et al. · 2013 [cited by applicant]
US 20130245304A1 · Schubert et al. · 2013 [cited by applicant]
US 20140256844A1 · Henning et al. · 2014 [cited by applicant]
US 20160075918A1 · Bögershausen et al. · 2016 [cited by applicant]
US 20160208050A1 · Klotzbach · 2016 [cited by examiner]
US 20170298250A1 · Anselmann et al. · 2017 [cited by applicant]
US 20180134850A1 · Knott et al. · 2018 [cited by applicant]
US 20180319823A1 · Knott et al. · 2018 [cited by applicant]
US 20190100625A1 · Knott et al. · 2019 [cited by applicant]
US 20190106441A1 · Knott et al. · 2019 [cited by applicant]
US 20200055991A1 · Knott et al. · 2020 [cited by applicant]
US 20200055992A1 · Knott · 2020 [cited by examiner]
US 20200339612A1 · Knott et al. · 2020 [cited by applicant]
US 20200377524A1 · Knott et al. · 2020 [cited by applicant]
US 20200377525A1 · Knott et al. · 2020 [cited by applicant]
US 20200377526A1 · Knott et al. · 2020 [cited by applicant]
US 20200377640A1 · Knott et al. · 2020 [cited by applicant]
US 20200377660A1 · Knott et al. · 2020 [cited by applicant]
US 20200377663A1 · Favresse et al. · 2020 [cited by applicant]
US 20200377665A1 · Knott et al. · 2020 [cited by applicant]
US 20200377666A1 · Knott et al. · 2020 [cited by applicant]
US 20200377667A1 · Favresse et al. · 2020 [cited by applicant]
US 20200377668A1 · Favresse et al. · 2020 [cited by applicant]
US 20200377669A1 · Knott et al. · 2020 [cited by applicant]
US 20200377686A1 · Knott et al. · 2020 [cited by applicant]
US 20210130551A1 · Knott et al. · 2021 [cited by applicant]
US 20210163687A1 · Knott et al. · 2021 [cited by applicant]
US 20210171719A1 · Knott et al. · 2021 [cited by applicant]
US 20210253799A1 · Knott et al. · 2021 [cited by applicant]
US 20210371598A1 · Knott et al. · 2021 [cited by applicant]
US 20210403753A1 · Schulte et al. · 2021 [cited by applicant]
US 20220033587A1 · Knott et al. · 2022 [cited by applicant]
US 20220119617A1 · Knott et al. · 2022 [cited by applicant]
US 20220177652A1 · De Gans et al. · 2022 [cited by applicant]
CA 3051621A1 · 2020 [cited by examiner]
CA 3121101A1 · 2020 [cited by examiner]
CN 105670501 · 2016 [cited by applicant]
CN 105131293 · 2018 [cited by applicant]
DE 3412648 · 1987 [cited by applicant]
DE 202010017915 · 2013 [cited by applicant]
DE 202009019002 · 2015 [cited by applicant]
EP 0157318 · 1989 [cited by applicant]
EP 0514737 · 1992 [cited by applicant]
EP 0964020 · 2003 [cited by applicant]
EP 0771835 · 2005 [cited by applicant]
EP 2198932 · 2010 [cited by applicant]
EP 3611215 · 2020 [cited by applicant]
EP 4011992 · 2022 [cited by applicant]
WO 2012040305 · 2012 [cited by applicant]
WO 2014187972 · 2014 [cited by applicant]
WO 2019200579 · 2019 [cited by applicant]
European Search Report dated May 4, 2022, in EP Application No. 21210450.9, 5 pages. [cited by applicant]
Herman F. Mark et al., “Silicones”, Subito, Encyclopedia of polymer science & technology, Nov. 16, 2020, pp. 1112-1116. [cited by applicant]
Ratner et al., “Biomaterials Science”, An Introduction to Materials in Medicine, Second Edition, 2004, pp. 83-84. [cited by applicant]
Jaumann Manfred et al., “Hyperbranched Polyalkoxysiloxanes via AB [cited by applicant]
Jaumann Manfred, “Hyperbranched Polyalkoxysiloxanes Synthesis, Characterization and Applications”, Sep. 4, 2008, pp. 1-259. [cited by applicant]
Robeyns et al., “Synthesis, characterization and modification of silicone resins: An ‘Augmented Review’”, Progress in Organic Coatings, vol. 125, 2018, pp. 287-315. [cited by applicant]
U.S. Appl. No. 10/083,763, filed Feb. 25, 2002, Burkhart et al. [cited by applicant]
U.S. Appl. No. 12/414,805, filed Mar. 31, 2009, Schubert et al. [cited by applicant]
U.S. Appl. No. 13/650,221, filed Oct. 12, 2012, Knott et al. [cited by applicant]
U.S. Appl. No. 14/282,608, filed May 20, 2014, Henning et al. [cited by applicant]
U.S. Appl. No. 13/153,622, filed Jun. 6, 2011, Knott et al. [cited by applicant]
U.S. Appl. No. 15/510,282, filed Mar. 10, 2017, Anselmann et al. [cited by applicant]
U.S. Appl. No. 16/759,413, filed Apr. 27, 2020, Knott et al. [cited by applicant]
U.S. Appl. No. 17/147,592, filed Jan. 13, 2021, Knott et al. [cited by applicant]
U.S. Appl. No. 17/297,372, filed May 26, 2021, Knott et al. [cited by applicant]
U.S. Appl. No. 16/851,385, filed Apr. 17, 2020, Knott et al. [cited by applicant]
U.S. Appl. No. 17/457,944, filed Dec. 7, 2021, De Gans et al. [cited by applicant]
U.S. Appl. No. 17/145,558, filed Jan. 11, 2021, Knott et al. [cited by applicant]
U.S. Appl. No. 17/355,385, filed Jun. 23, 2021, Schulte et al. [cited by applicant]
U.S. Appl. No. 17/239,011, filed Apr. 23, 2021, Knott et al. [cited by applicant]
U.S. Appl. No. 17/476,417, filed Sep. 15, 2021, Knott et al. [cited by applicant]
European Search Report dated Apr. 19, 2023, in European Application No. 22207737.2, 6 pages. [cited by applicant]